SCHEMBL24938765

SCHEMBL24938765

COc1ccc2oc(=O)cc(CCl)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 1.00
KDM4E B2RXH2 5/20 0.63
ALDH1A1 P00352 4/20 0.63
HPGD P15428 4/20 0.63
HSD17B10 Q99714 2/20 0.63
PON1 P27169 1/20 0.61
MTNR1A P48039 1/20 0.61
MTNR1B P49286 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.57
NPC1 O15118 1/20 0.57
MAPT P10636 1/20 0.57
CASP3 P42574 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
SENP8 Q96LD8 1/20 0.57
SENP7 Q9BQF6 1/20 0.57
SENP6 Q9GZR1 1/20 0.57
CYP2D6 P10635 2/20 0.56
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6229629 0.88 DYRK1A (0.78) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL8707352 0.85 DYRK1A (0.74) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL27470491 0.82 DYRK1A (0.70) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL23634920 0.82 DYRK1A (0.69) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL68260 0.80 PON1 (0.66) DYRK1AKDM4EALDH1A1HSD17B10PON1
SCHEMBL5461532 0.80 KDM4E (0.69) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15842463 0.78 KDM4E (0.71) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7115071 0.78 ALDH1A1 (1.00) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL3914588 0.76 KDM4E (0.69) DYRK1AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL15245387 0.76 MCL1 (0.66) DYRK1AKDM4EALDH1A1PON1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158152-A1 PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME MEDSHINE DISCOVERY INC. (CN) 2023-05-25 US disclosed
WO-2023001028-A1 HETEROARYL-3-PIPERIDINEDIONE COMPOUND AND USE THEREOF 南京明德新药研发有限公司 2023-01-26 WO disclosed
EP-4122925-A1 PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME Medshine Discovery Inc. (CN) 2023-01-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158152-A1 PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME PSMA6, PSMC1, PSMA1 DYRK1A 3072/4885KDM4E 1251/4885ALDH1A1 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.